Elanco has issued a recall for a specific batch of Flukiver 5% w/v Oral Suspension due to a labeling issue. The recall affects batch 22FQ211 and is classified as a Class III recall, meaning that the product is not likely to cause adverse health consequences.
The recall was initiated by Elanco due to an incorrect lot number on the affected batch. The company is urging wholesalers to check their inventory and quarantine any products from batch 22FQ211 to prevent further distribution.
Elanco is taking all necessary measures to ensure the recall is conducted effectively and efficiently. The company is contacting wholesalers directly to provide information on the recall and to coordinate the return of the affected products.
Consumers who have purchased Flukiver 5% w/v Oral Suspension from batch 22FQ211 are advised not to use the product and to contact their healthcare provider if they have any concerns.
Elanco has initiated a Class III recall of Flukiver 5% w/v Oral Suspension for batch 22FQ211 due to a labeling error. Wholesalers are urged to examine their inventory and quarantine any affected products, while consumers are advised not to use the product and to seek medical advice if necessary. Elanco is committed to ensuring the recall is conducted in a safe and effective manner.
Source: Gov[Dot]UK
